Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
New research review suggests that post-stroke fatigue is a symptom independent of depression, pain and sleep problems, and may depend on the 'excitability' of the movement part of the brain.
UK Stroke Forum 2016 took place from Monday to Wednesday (28-30 November) at the ACC in Liverpool. UK Stroke Forum is the largest multidisciplinary stroke event in the UK, attracting over 1400 delegates from across the stroke care pathway.
The Stroke Association is a member of the Association of Medical Research Charities (AMRC), which is the national membership organisation of leading medical and health research charities in the UK. Published today, the AMRC's 'Making a difference: Impact report 2017' highlights how the research of its member charities makes a difference.
Published in the journal, Neurorehabilitation and Neural Repair, a new Stroke Association funded study suggests people who are in the chronic stages of stroke will improve their reaching accuracy at the speed at which they train their reaching movement.
This study will test arm training to encourage a functionally useful contribution to recovery from the side of the brain unaffected by stroke (the 'non-stroke hemisphere'), and whether this is only possible early after stroke.
We are delighted to invite applications for a 2018 Clinical Study in the field of stroke, which will be awarded jointly between the Stroke Association and the British Heart Foundation. Deadline for outline applications is 5pm on Monday 15 January 2018.
Postgraduate fellowship: What is the impact of damaged thinking ability caused by a spontaneous bleed in the brain?
Researchers at Foothills Hospital in Calgary, Canada have done research that claims that TIAs (mini strokes) could cause long-term disability, and that clot busting drugs like Actilyse could be used to treat them.
Using genetics to understand why disease of the small blood vessels in the brain occurs.